Peptide mimetics may substitute for carbohydrate antigens in vaccine design
applications. At present, the structural and immunological aspects of anti
genic, mimicry, which translate into immunologic mimicry, as well as the fu
nctional correlates of each, are unknown. In contrast to screening peptide
display libraries, we demonstrate the feasibility of a structure-assisted v
accine design approach to identify functional mimeotopes. By using concanav
alin A (ConA), as a recognition template, peptide mimetics reactive with Co
nA were identified. Designed peptides were observed to compete with synthet
ic carbohydrate probes for ConA binding, as demonstrated by enzyme-linked i
mmunosorbent assay and isothermal titration calorimetry (ITC) analysis' ITC
measurements indicate that a multivalent form of one particular mimetic bi
nds to ConA with.. ar affinity as does trimannoside. Splenocytes from mimeo
tope-immunized mice display a peptide-specific cellular response,, confirmi
ng a T-cell-dependent nature for the mimetic. As ConA binds to the Envelope
protein of the human immunodeficiency virus, type I (HIV-1), we observed t
hat mimeotope-induced serum also binds to HIV-1-infected cells, as assessed
by flow cytometry, and could neutralize T-cell line adapted HIV-1 isolates
in vitro, albeit at low titers. These studies emphasize that mimicry is ba
sed more upon functional rather than structural determinants that regulate
mimeotope-induced T-dependent antibody responses to polysaccharide and emph
asize that rational approaches can be employed to develop further vaccine c
andidates.